MedPath

HASUMI INTERNATIONAL RESEARCH FOUNDATION

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
1 (100.0%)

IKKb-matured, RNA-loaded Dendritic Cells for Metastasised Uveal Melanoma

Phase 1
Conditions
Melanoma, Uveal Metastatic
First Posted Date
2020-04-07
Last Posted Date
2022-03-17
Lead Sponsor
Hasumi International Research Foundation
Target Recruit Count
12
Registration Number
NCT04335890
Locations
πŸ‡©πŸ‡ͺ

University Hospital Erlangen Dept. of Dermatology, Erlangen, Bavaria, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.